OTC - ACTIVE INGREDIENT SECTION
Undecylenic Acid 25%
Jorvinl Nail Fungus Treatment
- Manufacturer
- Guangzhou Huixue Biotechnology Co., Ltd.
- Effective date
- 2026-02-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:36:46
Label at a glance#
ProductJorvinl Nail Fungus Treatment
Active ingredientUNDECYLENIC ACID
Label structure11 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
Aloe Vera Extract, Helianthus Annuus (Sunflower) Seed Oil, Cyclopentasiloxane, Prunus Armeniaca (Apricot) Kernel Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Eugenia Caryophyllus (Clove) Bud Oil, Lavandula Angustifolia (Lavender) Oil, Hakka Yu, Tocopherol, Origanum Vulgare Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Eucalyptol.
OTC - PURPOSE SECTION
Antifungal
INDICATIONS & USAGE SECTION
For the treatment of nail fungus and associated symptoms, including discoloration, thickening, splitting, crumbling, and brittleness
WARNINGS SECTION
Warnings For external use only. De not use on children under 2 years of age unless directed by a doctor. When using this product, avoid contact with the eyes. tion occurs or if there is no improvement within 4 weeks. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Store at room temperature. Avoid direct sunlight.
OTC - WHEN USING SECTION
1. Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor. Gently file the nail to make it thinner and remove debris, being cautious not to harm the nail bed. For best results, file nails every 2-3 days. 2. Supervise children in the use of this product. For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. To prevent athlete's foot, apply once or twice daily (morning and/or night). For toe fungus, apply to skin around the nail and cuticle. Visible improvement may be seen in as little as 7 days. Continue regular use to help prevent fungus regrowth.
OTC - DO NOT USE SECTION
For external use only. Do not use on children under 2 years of age unless directed by a doctor. When using this product, avoid contact with the eyes. Stop use and ask a doctor if irritation occurs or if there is no improvement within 4 weeks.
OTC - STOP USE SECTION
irritation occurs or if there is no improvement within 4 weeks.
DOSAGE & ADMINISTRATION SECTION
Twice each day,(1ml)each time.7 days supply
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 87204-163-01 | Jorvinl Nail Fungus Treatment | 15 mL in 1 BOTTLE, PLASTIC | LIQUID | 15 | 1 |
Products#
Every source-derived product name is available through these pages.
- Jorvinl Nail Fungus Treatment
- Undecylenic Acid 25%
- EUCALYPTOL
- TOCOPHEROL
- CYCLOPENTASILOXANE
- UNDECYLENIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 87204-163 | 87204-163-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EUCALYPTOL | RV6J6604TK | IACT |
| TOCOPHEROL | R0ZB2556P8 | IACT |
| CYCLOPENTASILOXANE | 0THT5PCI0R | IACT |
| UNDECYLENIC ACID | K3D86KJ24N | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Jorvinl Nail Fungus Treatment | UNDECYLENIC ACID 25% | Guangzhou Huixue Biotechnology Co., Ltd. | 49d88844-9cb0-f575-e063-6394a90a0d2f | 2026-02-02 | Warnings | 87204-163-01 87204-163 87204016301 49d88844-9cb1-f575-e063-6394a90a0d2f 49d88844-9cb0-f575-e063-6394a90a0d2f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.